Gateway Advisory, LLC Neurocrine Biosciences Inc Transaction History
Gateway Advisory, LLC
- $558 Million
- Q3 2024
A detailed history of Gateway Advisory, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Gateway Advisory, LLC holds 2,856 shares of NBIX stock, worth $357,028. This represents 0.06% of its overall portfolio holdings.
Number of Shares
2,856
Previous 2,309
23.69%
Holding current value
$357,028
Previous $317,000
3.47%
% of portfolio
0.06%
Previous 0.06%
Shares
5 transactions
Others Institutions Holding NBIX
# of Institutions
648Shares Held
96.9MCall Options Held
800KPut Options Held
565K-
Black Rock Inc. New York, NY14.2MShares$1.77 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.24 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$692 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$608 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$334 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...